Medication info
Mikatan Plus Tablet 80/12.5 mg

Mikatan Plus Tablet 80/12.5 mg

Prescription medicationTabletOral
Ingredient · strength
Telmisartan›80mg / 1 tabletHydrochlorothiazide›12.5mg / 1 tablet
Manufacturer / importer
SS Pharm Co., Ltd.
Appearance
An oval-shaped tablet consisting of a white and pink layer, with the white layer possibly having pink specks.
Packaging
30 tablets (10 tablets/PTPX3)
Approval status
Active

MFDS item code 201000878 · Notified 2010.01.26 · Insurance code 652602830

Summary

Main use
Treatment of essential hypertension not controlled with telmisartan alone
Who takes it
Adults · Children
Adult dose
For patients whose blood pressure is not adequately controlled with telmisartan alone, take once daily with a drink, with or without food. Before switching to this medicine, which contains fixed doses of each component, it is recommended that the doses of the individual components be adjusted separately according to the patient's needs. When clinically appropriate, a direct switch from monotherapy to this medicine may also be considered. - The telmisartan/hydrochlorothiazide combination 40/12.5mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 40mg. - The telmisartan/hydrochlorothiazide combination 80/12.5mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 80mg. - The telmisartan/hydrochlorothiazide combination 80/25mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 80mg and hydrochlorothiazide 12.5mg administered concomitantly as separate products or as a combination product. Sodium or volume depletion should be corrected before starting this medicine. No dosage adjustment is required in patients with mild to moderate renal impairment. This medicine should not be administered to patients with severe renal impairment (creatinine clearance<30mL/min). Periodic monitoring of renal function is recommended. This medicine should be administered with caution to patients with mild to moderate hepatic impairment. The daily dose of this medicine should not exceed 40/12.5mg. This medicine should not be administered to patients with severe hepatic impairment (see Precautions for Use, section 2). Thiazide diuretics should be administered with caution to patients with impaired liver function. No dosage adjustment is required.
Child dose
The safety and efficacy of this medicine have not been established in children under 18 years of age.

Ingredients

Manufacturer
SS Pharm Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled with telmisartan alone

  • Essential hypertension
View approved original text

This medication is used for patients with essential hypertension who find it difficult to control blood pressure with telmisartan alone. Administering this drug additionally helps effectively lower and regulate blood pressure. It can greatly assist in the management of the patient's blood pressure, so please take it with confidence.

How to take

Adult dose

For patients whose blood pressure is not adequately controlled with telmisartan alone, take once daily with a drink, with or without food. Before switching to this medicine, which contains fixed doses of each component, it is recommended that the doses of the individual components be adjusted separately according to the patient's needs. When clinically appropriate, a direct switch from monotherapy to this medicine may also be considered. - The telmisartan/hydrochlorothiazide combination 40/12.5mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 40mg. - The telmisartan/hydrochlorothiazide combination 80/12.5mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 80mg. - The telmisartan/hydrochlorothiazide combination 80/25mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 80mg and hydrochlorothiazide 12.5mg administered concomitantly as separate products or as a combination product. Sodium or volume depletion should be corrected before starting this medicine. No dosage adjustment is required in patients with mild to moderate renal impairment. This medicine should not be administered to patients with severe renal impairment (creatinine clearance<30mL/min). Periodic monitoring of renal function is recommended. This medicine should be administered with caution to patients with mild to moderate hepatic impairment. The daily dose of this medicine should not exceed 40/12.5mg. This medicine should not be administered to patients with severe hepatic impairment (see Precautions for Use, section 2). Thiazide diuretics should be administered with caution to patients with impaired liver function. No dosage adjustment is required.

Child dose

The safety and efficacy of this medicine have not been established in children under 18 years of age.

Precautions

This medication can cause serious harm to the fetus, especially during the second and third trimesters of pregnancy, so if pregnancy is confirmed, it must be stopped immediately. This drug should not be used by those who are allergic to the ingredients or additives, as well as pregnant or breastfeeding women, those with issues related to bile or the biliary tract, and patients with severe liver or kidney disease. Elderly patients or those with high potassium levels, poor liver function, heart valve disease, or cerebrovascular disease should use this drug with caution. This medication can cause photosensitivity reactions on the skin, so it is important to minimize sun exposure and consult a doctor immediately if skin abnormalities occur. During use, symptoms such as dizziness, low blood pressure, and electrolyte imbalances (potassium, sodium, magnesium, etc.) may arise, so regular blood tests are recommended. This drug may interact with other antihypertensives, diuretics, lithium, potassium supplements, etc., so it is essential to consult with a physician or pharmacist before co-administration. Driving or operating machinery may cause drowsiness or dizziness, so caution is advised. In case of overdose, symptoms such as low blood pressure, electrolyte imbalances, and dehydration may occur, requiring immediate medical attention. It is not recommended for use in children under 18 years of age as safety and efficacy have not been established.

Side effects

  • Bronchitis
  • pharyngitis
  • sinusitis
  • hypokalemia
  • hyperuricemia
  • hyponatremia
  • anxiety
  • depression
  • insomnia
  • sleep disorders
Show 175 more
  • dizziness
  • fainting
  • paresthesia
  • visual impairment
  • blurred vision
  • vertigo
  • tachycardia
  • arrhythmia
  • hypotension
  • orthostatic hypotension
  • dyspnea
  • respiratory distress
  • pneumonia
  • pulmonary edema
  • diarrhea
  • dry mouth
  • bloating
  • abdominal pain
  • constipation
  • dyspepsia
  • vomiting
  • gastritis
  • liver dysfunction
  • liver disease
  • angioedema
  • erythema
  • pruritus
  • rash
  • hyperhidrosis
  • urticaria
  • back pain
  • muscle cramps
  • myalgia
  • arthralgia
  • limb pain
  • systemic lupus erythematosus
  • erectile dysfunction
  • chest pain
  • influenza-like illness
  • pain
  • increased blood uric acid
  • increased blood creatinine
  • increased blood creatine phosphokinase
  • increased liver enzymes
  • upper respiratory tract infection
  • urinary tract infection
  • cystitis
  • sepsis
  • anemia
  • eosinophilia
  • thrombocytopenia
  • anaphylactic reaction
  • hyperkalemia
  • hypoglycemia
  • drowsiness
  • bradycardia
  • cough
  • interstitial lung disease
  • dysgeusia
  • eczema
  • drug rash
  • toxic epidermal necrolysis
  • bone pain
  • renal dysfunction
  • weakness
  • increased blood creatine phosphokinase
  • decreased hemoglobin
  • sialadenitis
  • non-melanoma skin cancer
  • thrombocytopenic purpura
  • hemolytic anemia
  • bone marrow failure
  • leukopenia
  • agranulocytosis
  • hypersensitivity
  • aplastic anemia
  • decreased appetite
  • hypomagnesemia
  • hyperglycemia
  • hypercalcemia
  • hypochloremic metabolic alkalosis
  • yellow vision
  • acute myopia
  • angle-closure glaucoma
  • choroidal effusion
  • necrotizing vasculitis
  • acute respiratory distress syndrome
  • nausea
  • pancreatitis
  • jaundice
  • cholestasis
  • photosensitivity reaction
  • toxic epidermal necrolysis
  • lupus-like syndrome
  • systemic lupus erythematosus
  • acute renal failure
  • diabetes
  • renal dysfunction
  • weakness
  • fever
  • nausea
  • gastrointestinal bleeding
  • esophagitis
  • headache
  • tremor
  • facial flushing
  • malaise
  • fatigue
  • weight loss
  • proteinuria
  • pruritus
  • myalgia
  • feeling of floating
  • lip and hand tremor
  • hypersensitivity
  • decreased vision
  • hypotension
  • tachycardia
  • bradycardia
  • fainting
  • drowsiness
  • orthostatic hypotension
  • angioedema
  • thrombocytopenia
  • thrombocytopenic purpura
  • hemolytic anemia
  • bone marrow failure
  • leukopenia
  • agranulocytosis
  • anaphylactic reaction
  • hypokalemia
  • hyperlipidemia
  • hyponatremia
  • hyperuricemia
  • decreased appetite
  • hypomagnesemia
  • hyperglycemia
  • hypercalcemia
  • hypochloremic metabolic alkalosis
  • depression
  • sleep disorders
  • dizziness
  • paresthesia
  • headache
  • visual impairment
  • vertigo
  • arrhythmia
  • orthostatic hypotension
  • diarrhea
  • nausea
  • vomiting
  • rash
  • urticaria
  • photosensitivity reaction
  • toxic epidermal necrolysis
  • lupus-like syndrome
  • systemic lupus erythematosus
  • muscle cramps
  • acute renal failure
  • erectile dysfunction
  • weakness
  • fever
  • dizziness
  • diarrhea
  • cough
  • nausea
  • headache
  • gastrointestinal bleeding
  • esophagitis
  • fatigue
  • weight loss
  • proteinuria
  • pruritus
  • myalgia
  • feeling of floating

Not everyone experiences these, and they can vary from person to person.

Storage

This drug should be stored in a sealed container to prevent exposure to air or moisture, with a safe storage temperature range between 1 degree and 30 degrees Celsius. This storage condition will help maintain the drug's effectiveness and prevent deterioration.

Appearance and packaging

Appearance

An oval-shaped tablet consisting of a white and pink layer, with the white layer possibly having pink specks.

Package unit

30 tablets (10 tablets/PTPX3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.